These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6877086)

  • 21. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
    Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
    Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
    Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.
    Sy SM; Wong N; Lee TW; Tse G; Mok TS; Fan B; Pang E; Johnson PJ; Yim A
    Eur J Cancer; 2004 May; 40(7):1082-94. PubMed ID: 15093586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.
    Sugimura H; Kohno T; Wakai K; Nagura K; Genka K; Igarashi H; Morris BJ; Baba S; Ohno Y; Gao C; Li Z; Wang J; Takezaki T; Tajima K; Varga T; Sawaguchi T; Lum JK; Martinson JJ; Tsugane S; Iwamasa T; Shinmura K; Yokota J
    Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):669-74. PubMed ID: 10744126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population.
    Miao R; Gu H; Liu H; Hu Z; Jin G; Wang H; Wang Y; Sun W; Ma H; Chen D; Tian T; Jin L; Wei Q; Lu D; Huang W; Shen H
    Lung Cancer; 2008 Dec; 62(3):281-6. PubMed ID: 18495292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl hydrocarbon receptor gene polymorphisms affect lung cancer risk.
    Kim JH; Kim H; Lee KY; Kang JW; Lee KH; Park SY; Yoon HI; Jheon SH; Sung SW; Hong YC
    Lung Cancer; 2007 Apr; 56(1):9-15. PubMed ID: 17174437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIK3CA gene amplification in Japanese non-small cell lung cancer.
    Kawano O; Sasaki H; Okuda K; Yukiue H; Yokoyama T; Yano M; Fujii Y
    Lung Cancer; 2007 Oct; 58(1):159-60. PubMed ID: 17681398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung.
    Pavanello S; B'chir F; Pulliero A; Saguem S; Ben Fraj R; El Aziz Hayouni A; Clonfero E; Mastrangelo G
    Lung Cancer; 2007 Sep; 57(3):266-72. PubMed ID: 17509724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer.
    Hu Z; Shao M; Chen Y; Zhou J; Qian J; Xu L; Ma H; Wang X; Xu Y; Lu D; Shen H
    Cancer Lett; 2006 May; 236(2):269-75. PubMed ID: 16019127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
    Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
    Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M; Tagawa M; Kimura H; Kakisawa K; Shirasawa H; Fujisawa T
    Int J Oncol; 1998 Mar; 12(3):577-81. PubMed ID: 9472095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers.
    Kunitoh H; Sekine I; Kubota K; Tamura T; Shinkai T; Kodama T; Saijo N; Naruke T; Yamaguchi N
    Cancer; 1999 Oct; 86(7):1182-8. PubMed ID: 10506702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
    Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
    Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphism of CYP2D6 and lung cancer risk.
    Shaw GL; Falk RT; Frame JN; Weiffenbach B; Nesbitt JC; Pass HI; Caporaso NE; Moir DT; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):215-9. PubMed ID: 9521436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chromosomal imbalance in primary lung squamous cell carcinoma and their relationship with smoking].
    Yan WS; Song LY; Wei WD; Li A; Liang QW; Liu JH; Fang Y
    Ai Zheng; 2005 Jan; 24(1):47-52. PubMed ID: 15642199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
    Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
    Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.
    Sato S; Nakamura Y; Tsuchiya E
    Cancer Res; 1994 Nov; 54(21):5652-5. PubMed ID: 7923212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
    Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.